Technicals for Glenmark Pharmaceuticals Limited

Price Summary

Glenmark Pharmaceuticals Limited's stock started the year at 2193.9, climbed to a high of 2222.0, fell to 2148.2, and closed -0.91% lower at 2174.0, with 1090064 shares traded on 2026-06-03.
Over the course of 52 weeks, the stock peaked at 2417.9 and hit a low of 0.0.

Technicals

Support and Resistance: The current price of 2174.0 for GLENMARK is supported at 2136.7 and faces resistance at 2272.7. These levels indicate that 2136.7 could act as a floor, while 2272.7 might limit any further price increases.


Aroon: The AROON is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.


Bol. Bands: The current price has crossed below the lower Bollinger Band, indicating that the market may be oversold. This move suggests that selling pressure has been strong enough to push prices below a key support level. While this breach could mean the bearish trend will persist, it might also signal a potential reversal if the market begins to attract buying interest at these lower prices.


Parabolic SAR: The PSAR maintains a bearish outlook for GLENMARK, establishing a key resistance level that could limit further gains. This ongoing bearish trend suggests that the market may struggle to overcome this resistance, keeping upward movement subdued.


Stochastic: The Stochastic K-line has dropped beneath the D-line and is below 20, indicating a mildly bearish outlook. This suggests that the market might experience some downward movement, though the bearish sentiment is mild. Investors should keep an eye on this trend for further confirmation.


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position for Glenmark Pharmaceuticals Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.


In order to draw meaningful inferences from a company's technical data, it is essential to first consider its fundamentals. This includes reviewing financial metrics like revenue, profit margins, and debt-to-equity ratios. Additionally, understanding the broader industry landscape, including market trends and competitive pressures, is crucial. By integrating these insights with the company's technical performance, such as stock price fluctuations and trading volume, one can make more informed investment decisions.